<?xml version="1.0" encoding="UTF-8"?>
<p>Our findings indicate that corticosteroid treatment did not influence virus clearance time, hospital length of stay, or duration of symptoms in patients with mild COVID‐19. Pathology findings indicate that ARDS plays a crucial role in COVID‐19 cases with fatal outcomes,
 <xref rid="mja250577-bib-0023" ref-type="ref">23</xref> and early administration of corticosteroids might reduce the risk of ARDS in virus infections.
 <xref rid="mja250577-bib-0024" ref-type="ref">24</xref> However, we could not assess the efficacy of early corticosteroid therapy for preventing ARDS, as none of our patients developed it.
</p>
